Sign in
8-K

Current Report

CytomX Therapeutics, Inc. Filed Acc 0001564590-17-013546

Auditor change

  • Item 4.01 Changes in the registrant's certifying accountant

From the SEC's structured data for this filing

Loading ctmx-8k_20170712.htm…